Characteristics | N = 9 |
---|---|
Age | 84.8 ± 5.1 |
Male | 67 % |
Euroscore (Logistic) | 23.5 ± 12.5 % |
Peripheral artery disease | 11 % |
End stage renal failure | 0 |
Creatinine (mg/dL) | 1.52 ± 0.6 |
LV-Ao peak gradient | 66.4 ± 26.2 |
LV-Ao mean gradient | 43.9 ± 18.2 |
AVA (cm2) | 0.7 ± 0.1 |
Medtronic Corevalve Size | |
26 | 22 % |
29 | 56 % |
31 | 22 % |
Outcomes | |
Post-TAVR LV-AO peak gradient | 13.8 ± 6.4 |
Death within 30 days | 0 |
Stroke/TIA | 0 |
MI | 0 |
Pacemaker | 44 % |
Other Complications | 11 % |